alexa Vector|omicsgroup|Gene Technology

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Vector

Gene Technology is one of the leading Scholarly journals in Modern Biotechnology. The journal strives to add in theoretical and technological innovations as part of its publishing remit and is devoted to publishing the highest quality papers. The administration of the journal is integrative, reflecting the fact that imaging neuroscience is a multi-disciplinary science. Viral vectors are more efficient for gene delivery and expression than non-viral ones; however, viral vectors pose greater risks than non-viral vectors. Thus, viral vectors are generally not used for drug delivery, and instead non-viral vectors are used for delivering anticancer agents, synthetic oligonucleotides, antibodies, and small RNA molecules such as siRNA and microRNA. “Fuminori Kato, Hemagglutinating Virus of Japan Envelope Vectors as High-Performance Vehicles for Delivery of Small RNAs” OMICS is devoted to the prompt publication of original findings of the highest scientific priority and value that provide novel mechanistic insights, represent a clear advance over previous Studies and have the potential to generate exciting future research.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on June, 2014

Top